,,iii  #aaf? ,,congress  #a/ ,session   
,s4 ,,res4 #agg  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,april #cj1 #bjai ,ms4
 ,hirono 7= h]self & ,mr4 ,k+7 submitt$ 
! foll[+ resolution2 :i* 0 ref]r$ to !  
,committee on ,heal?1 ,education1       
,labor1 & ,p5sions  ,,resolution        
,express+ support = ! designation (     
,april #cj1 #bjai1 z ,national ,adult   
,hepatitis ,b ,vacc9ation ,aw>5ess ,day4
  ,:]eas1 z _m z #b1bjj1jjj individuals 
9 ! ,unit$ ,/ates are *ronically infect$
 ) hepatitis ,b1 & z _m z #b_/c ( ^?    
individuals are unaw>e ( ! infection2   
,:]eas hepatitis ,b is a viral infection
 ( ! liv] t is transmitt$ via infect$   
blood & o!r bodily fluids1 includ+      
?r\gh--  7#a7 "m-to-*ild transmission2 &
  7#b7 injection drug use2  ,:]eas      
individuals ) *ronic diseases1 su* z    
diabetes1 ,,hiv1 hepatitis ,c1 & *ronic 
liv] disease1 & individuals on          
hemodialysis1 are at an increas$ risk = 
hepatitis ,b co-infection2 ,:]eas !re is
 no cure = hepatitis ,b1 & individuals )

 *ronic hepatitis ,b require lifelong   
m$ical c>e2 ,:]eas *ronic hepatitis ,b  
is a common cause ( liv] canc]2 ,:]eas  
#a 9 e #d individuals ) unmanag$ *ronic 
hepatitis ,b w develop liv] canc]1      
cirrhosis1 or liv] failure1 ) liv] canc]
 hav+ a #e-ye> survival rate ( only #ah 
p]c5t 9 ! ,unit$ ,/ates2 ,:]eas safe &  
highly effective vacc9es to protect     
aga9/ hepatitis ,b are available2       
,:]eas1 9 accordance ) univ]sal *ildhood
 hepatitis ,b vacc9ation recomm5dations 
9 ! ,unit$ ,/ates1 infants & *ildr5 9 ! 
,unit$ ,/ates h r\t9ely be5 vacc9at$    
aga9/ hepatitis ,b s9ce ! #aiijs2 ,:]eas
 ! hepatitis ,b vacc9e1 :i* is #ie p]c5t
 effective & 0 ! fir/ anticanc] vacc9e  
to be develop$1 is project$ to prev5t   
#caj1jjj1jjj cases ( hepatitis ,b       
worldwide f #aiij to #bjbj2 ,:]eas only 
#be p]c5t ( adults 9 ! ,unit$ ,/ates are
 vacc9at$ aga9/ hepatitis ,b2 ,:]eas !  
numb] ( report$ acute hepatitis ,b cases
 increas$ by #bj p]c5t nationwide 9     
#bjae2 ,:]eas1 z a result ( ! opioid    

epidemic1 !re h be5 significant regional
 increases 9 acute hepatitis ,b cases 9 
! ,unit$ ,/ates1 includ+--  7#a7 a      
report$ #gbi-p]c5t increase f #bjae to  
#bjag 9 ,ma9e2  7#b7 a report$          
#aad-p]c5t increase f #bjji to #bjac 9  
,k5tucky1 ,we/ ,virg9ia1 & ,t5nessee2   
7#c7 a report$ #gh-p]c5t increase 9     
#bjag 9 s\!a/]n ,massa*usetts2 &  7#d7 a
 report$ #fb-p]c5t increase f #bjab to  
#bjaf 9 ,nor? ,c>ol9a2  ,:]eas1 accord+ 
to ! ,c5t]s = ,disease ,control &       
,prev5tion1 hepatitis ,b is #ej to #ajj 
times m infecti\s ?an ,,hiv1 & #e to #aj
 times m infecti\s ?an hepatitis ,c2 &  
,:]eas !re are significant              
opportunities1 p>ticul>ly )9 ! sett+ ( !
 opioid epidemic1 to prev5t new         
hepatitis ,b infections1 & !reby r$uce !
 incid5ce ( liv] canc] & cirrhosis1     
?r\gh ef=ts to--  7#a7 increase adult   
hepatitis ,b vacc9ation2 &  7#b7 ma9ta9 
*ildhood hepatitis ,b vacc9ation3 ,n[1  
!re=e1 be x  ,t ! ,s5ate-- 7#a7 supports
 ! designation ( ,april #cj1 #bjai1 z   

,national ,adult ,hepatitis ,b          
,vacc9ation ,aw>5ess ,day2  7#b7        
recognizes ! importance ( provid+       
support & enc\ragem5t-- 7,a7 = all      
individuals to be te/$ = hepatitis ,b2  
7,b7 = individuals susceptible to       
infection to be vacc9at$ aga9/ hepatitis
 ,b2 &  7,c7 = individuals diagnos$ )   
hepatitis ,b to be l9k$ to appropriate  
c>e2 &  7#c7 9 ord] to r$uce ! numb] (  
new hepatitis ,b infections & hepatitis 
,b-relat$ dea?s1 enc\rages a commitm5t  
to--  7,a7 increas+ adult hepatitis ,b  
vacc9ation rates2  7,b7 ma9ta9+ *ildhood
 hepatitis ,b vacc9ation rates2 &  7,c7 
promot+ provid] & community aw>5ess (   
adult hepatitis ,b vacc9ation4